SKI Market

A+| A| A-|

Indian Indices

Sensex

75,273.45 1,205.00
( 1.63%)

Global Indices

Nasdaq

46,438.76 293.69
(0.64%)

Dow Jones

6,611.15 33.78
(0.51%)

Hang Seng

53,715.15 1,462.87
(2.80%)

Nikkei 225

10,078.37 113.21
(1.14%)

Forex

USD-INR

93.79 0.26
(0.28%)

EUR-INR

108.70 0.48
(0.44%)

GBP-INR

125.65 0.64
(0.51%)

JPY-INR

0.59 0.00
(0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Zim Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541400

INE518E01015

52.0221666

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZIMLAB

42.13

340.37

EPS(TTM)

Face Value()

Div & Yield %

1.51

Back

piramal capital & housing finance ltd

Valiant Organics consolidated net profit declines 33.15% in the December 2025 quarter

Feb 14,2026

Net profit of Valiant Organics declined 33.15% to Rs 3.65 crore in the quarter ended December 2025 as against Rs 5.46 crore during the previous quarter ended December 2024. Sales declined 14.77% to Rs 159.27 crore in the quarter ended December 2025 as against Rs 186.86 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	159.27	186.86	-15
OPM %	8.26	8.20	-
PBDT	10.24	15.34	-33
PBT	0.13	6.36	-98
NP	3.65	5.46	-33

75,273.45 1,205.00 ( 1.63%)

46,438.76 293.69 (0.64%)

6,611.15 33.78 (0.51%)

53,715.15 1,462.87 (2.80%)

10,078.37 113.21 (1.14%)

93.79 0.26 (0.28%)

108.70 0.48 (0.44%)

125.65 0.64 (0.51%)

0.59 0.00 (0.41%)